The main text describes the production and characterization of monoclonal antibodies against p15, the structural analysis of the p15-4E2 complex, and the construction and evaluation of p15-VLPs.
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that 11 posters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results